Renaissance Capital logo

Commentary & News

US IPO Week Ahead: July’s first major IPOs feature healthcare and insurance


After a quiet post-holiday week, the July IPO market is set to bag its first major deals in the week ahead. Hospital operator Ardent Health (ARDT) plans to raise $300 million at a $3.0 billion market cap. Ardent states that it is the fourth largest privately held, for-profit operator of hospitals in the US. It operates a system of 30 acute care hospitals and more

US IPO Weekly Recap: 2 SPACs debut in quiet post-holiday week

Two SPAC debuted this week, and one company completed an uplisting from the OTC. Meanwhile, three IPOs and two SPACs submitted initial filings this past week. Two SPACs priced this past week: SIM Acquisition I (SIMAU), which raised $200 million to target healthcare, and Launch One Acquisition (LPAAU), which also raised $200 million to more

Neuro-inflammation biotech Jupiter Neurosciences revives $12 million IPO with revised terms


Jupiter Neurosciences, a Phase 1 biotech developing an oral therapy for neuro-inflammation, revised the terms for its upcoming IPO on Friday. In its latest filing, the company also replaced sole bookrunner Spartan Capital Securities with Revere Securities, and disclosed updated financials. Prior to today's filing, Jupiter Neurosciences had not updated its prospectus more

Canadian carbon products producer AdvEn files and sets terms for an $8 million US IPO


AdvEn, a pre-revenue Canadian producer of advanced super activated carbon products, filed on Friday with the SEC to raise up to $8 million in an initial public offering. The Nisku, Canada-based company plans to raise $8 million by offering 1.6 million shares at a price range of $4 to $6. At the midpoint of the proposed range, AdvEn would command a fully diluted market value of $ more